We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Watson to Acquire Andrx After Firms Sell Rights to Products
Watson to Acquire Andrx After Firms Sell Rights to Products
November 14, 2006
The FTC has given Watson Pharmaceuticals permission to buy Andrx as long as the two sell off certain assets, including Andrx’s portfolio of oral contraceptives.